ECHO-Chicago: Hepatitis C (Session XVIII)
The ECHO-Chicago curriculum in Hepatitis C (HCV) is designed to expand primary care capacity for HCV screening and evidenced-based care at community health centers in some of Chicago’s most underserved neighborhoods. HCV has surpassed HIV/AIDS as the leading chronic virus infection leading to death in the United States. Early detection and treatment in the primary care setting can contribute to lower rates of morbidity and mortality, reduce the risk of disease progression, and maximize the benefits of emerging treatment options. ECHO-Chicago training provides primary care providers with the knowledge to identify persons at risk for HCV and conduct risk assessments, test, diagnose, counsel, stage, monitor and treat persons with HCV.
The target audience for this activity includes phyisicians specializing in internal medicine, family medicine and infectious disease.
At the conclusion of this activity, participatants will be able to:
- Identify patients at-risk for Hepatitis C and the need for testing;
- Describe staging and cirrhosis of the liver;
- Recognize proper treatment options based on genotype.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.